ELMED is proud to offer the medical profession worldwide an innovative, effective and advanced Lithotripsy Systems.
ELMED Lithotripsy Systems is the first manufacturer of ESWL Systems in Turkey. ELMED is involved in designing, developing, Manufacturing, exporting and servicing of advanced medical equipments for the urology market. It was founded in Ankara/TURKEY in 1991, in order to manufacture the first Turkish made Lithotripter. As the first international exhibition ELMED participated to AUA’96 Annual meeting in United States showing that Turkish lithotripsy systems could compete with leading world-brands in international markets.
Since then, ELMED is manufacturing high quality and highly efficient medical equipments and advanced products include extracorporeal and intracorporeal lithotripters for the treatment of urinary tract calculi. ELMED has a dedicated research and development department, which develops new products and continually improves the existing product range. ELMED produced the first Automatic Ultrasonic Localization System, which is applicable to any lithotripter.
ELMED has its own patent pending and design registrations for its products. The innovative design as new generation lithotripter, ELMED introduced its Complit model ESWL system, equipped with the movableIso-Centric shock wave head.
ELMED proudly announce that the new Intracorporeal Pneumatic & Ultrasonic Lithotripter; VIBROLITH Plus, and Extracorporeal Shock Wave Therapy (ESWT) Devices; MULTIMED Ortho and VIBROLITH Ortho, have been added to the product range for the use of medical profession worldwide.
With installations at numerous clinics and hospitals worldwide, ELMED has proven record for its ability to deliver high performance products and develop solutions that meet specific user requirements, while at the same time, ensuring high quality reliable service and cost effectiveness.
The entire range of products complies with international standards including quality assurance system; EN ISO 9001 and EN ISO 13485 and CE marked in accordance with Medical Device Directive (MDD 93/42/EEC), and GOST-R and Intracorporeal units FDA, as well.